BUSINESS● LOW1d ago · Sep 1, 2026, 3:15 AM
Small Cap Watch : XSO extends decline as Percheron funds AML trial and Nova advances US antimony plans
proactiveinvestors.com.au · Australia · north america
Small-cap stock XSO is continuing its decline as Percheron funds an AML trial and Nova progresses with its US antimony initiatives. This reflects specific company and market movements in the small-cap sector.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESS2m agoIn Morocco, can the gamble of an electric battery gigafactory prove successful?Jeune AfriqueBUSINESS25m agoMitsubishi Motors unveils revived Pajero model after 7-year hiatusJapan TodayBUSINESS27m agoPCM Fund declares $0.0642 dividendSeeking Alpha TechBUSINESS28m agoPIMCO High Income Fund declares $0.048 dividendSeeking Alpha Tech